Vitamin D Estimation With Giardia Lamblia Infections

Overview

investigators will take stool and blood samples from two groups of humans :- 1-group A (healthy group negative Giardia or control group),2-group B (positive Giardia or case group)then investigators make estimation for vitamin D in both groups then investigators try to find if there is relation between vitamin D level and Giardia lamblia infections

Full Title of Study: “Estimation of Vitamin D in Humans Infected With Giardia Lamblia”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: February 2022

Detailed Description

In this research a case- control study will be used) ,the percentage of case to control will be 1:1 the total number of samples 192 ,investigators will take stool and blood samples from two groups of humans :- 1-group A (healthy group negative Giardia or control group),2-group B (positive Giardia or case group)then investigators make estimation for vitamin D in both groups then investigators try to find if there is relation between vitamin D level and Giardia lamblia infections

Arms, Groups and Cohorts

  • Group A
    • 1-Group A(Healty group with negative Giardia lamblia or control group) 96 samples
  • Group B
    • 2- Group B(Cases group with positive Giardia lamblia )96 sample

Clinical Trial Outcome Measures

Primary Measures

  • fluctuation level of vitamin D level
    • Time Frame: 1 year
    • Estimation of vitamin D level in humans infected with Giardia lamblia

Participating in This Clinical Trial

Inclusion Criteria

  • patient infected with Giardia lamblia. Exclusion Criteria:

  • patient takes vitamin D supplement – patient has kidney disease- patient has liver disease-patient has a debilitating disease disease such as cancer or diabetes.

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Sohag University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Mohamed Sayed Farrag, principlal investigator – Sohag University
  • Overall Official(s)
    • Mohammed Sayed Farrag, Demonstrator, Principal Investigator, faculty of medicine sohag university
    • Mohammed Sayed Farrag, Demonstrator, Study Director, faculty of medicine sohag university
  • Overall Contact(s)
    • Mohammed Sayed Farrag, Demonstrator, 01110054887, mohameds_post@med.sohag.edu.eg

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.